Complete remission induced by rituximab in refractory, seronegative, muscle-specific, kinase-positive myasthenia gravis
- 18 December 2006
- journal article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 78 (7), 771
- https://doi.org/10.1136/jnnp.2006.093567
Abstract
Recently, there was a case of muscle-specific kinase (MuSK)-positive myasthenia gravis (MG) successfully treated with rituximab.2Keywords
This publication has 5 references indexed in Scilit:
- Successful treatment of MuSK antibody–positive myasthenia gravis with rituximabMuscle & Nerve, 2005
- Anti-CD20 antibody (Rituximab) therapy in a myasthenia gravis patient with follicular lymphomaAnnals of Hematology, 2005
- Effect of Rituximab on the Peripheral Blood and Cerebrospinal Fluid B Cells in Patients With Primary Progressive Multiple SclerosisArchives of Neurology, 2005
- Response of myasthenia gravis to rituximab in a patient with non‐Hodgkin lymphomaAmerican Journal of Hematology, 2004
- Rituximab for myasthenia gravis developing after bone marrow transplantNeurology, 2000